2022
DOI: 10.1021/acsnano.2c03597
|View full text |Cite
|
Sign up to set email alerts
|

Biosynthetic Dendritic Cell-Exocytosed Aggregation-Induced Emission Nanoparticles for Synergistic Photodynamic Immunotherapy

Abstract: Dendritic cell (DC)-derived small extracellular vesicles (DEVs) are recognized as a highly promising alternative to DC vaccines; however, the clinical testing of DEV-based immunotherapy has shown limited therapeutic efficacy. Herein, we develop a straightforward strategy in which DCs serve as a cell reactor to exocytose high-efficient DEV-mimicking aggregation-induced emission (AIE) nanoparticles (DEV-AIE NPs) at a scaled-up yield for synergistic photodynamic immunotherapy. Exocytosed DEV-AIE NPs inherit not o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
23
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 36 publications
(27 citation statements)
references
References 56 publications
(108 reference statements)
0
23
0
Order By: Relevance
“…Wang et al developed a nanosystem, DEV-AIE nanoparticles, which employed DCs as a cell reactor for exocytosis, achieving synergistic effects of PDT-immunotherapy. 64 The DEV-AIE nanoparticles were exocytosed by the biosynthesis of MBPN-TCyP with DCs. The DEV-AIE nanoparticles could trigger T cell activation due to the immune-modulation proteins from parental DCs.…”
Section: Pdt-immunotherapymentioning
confidence: 99%
“…Wang et al developed a nanosystem, DEV-AIE nanoparticles, which employed DCs as a cell reactor for exocytosis, achieving synergistic effects of PDT-immunotherapy. 64 The DEV-AIE nanoparticles were exocytosed by the biosynthesis of MBPN-TCyP with DCs. The DEV-AIE nanoparticles could trigger T cell activation due to the immune-modulation proteins from parental DCs.…”
Section: Pdt-immunotherapymentioning
confidence: 99%
“…In addition, to move to clinical trials, large scale production of EVs or EV mimetics needs to be considered ( Ou et al, 2021b ). To increase the production yield of EVs for PS delivery, Cao et al (2022) have developed a straightforward strategy in which dendritic cells are used as a cell reactor to exocytose high-efficient DEVs-mimicking AIE nanoparticles (DEVs-AIE). If this cell reactor approach can be applied for large scale production of EVs from various other cell types, EV delivery-based new generation of PSs may get close to clinical trials.…”
Section: Evs As a Ps Delivery System For Photodynamic Therapymentioning
confidence: 99%
“…7 Photodynamic therapy (PDT) and photothermal therapy (PTT) are two main strategies applied for phototherapy of cancer. 8,9 PDT mainly utilizes reactive oxygen species (ROS) generated from photosensitizers for the destruction of cancer cells and the disruption of microvascular, which has already been sanctioned by the Food and Drug Administration of America (FDA). 10,11 ROS molecules (e.g., hydrogen peroxide, superoxide, singlet oxygen, and hydroxyl radical) usually have very short life spans and narrow radiuses.…”
Section: ■ Introductionmentioning
confidence: 99%
“…The goal of cancer therapy is focused on the effective killing of cancer cells, while normal cells are not harmed. , Despite rapid progress in the understanding of conventional surgical procedures, chemotherapy, radiotherapy, and immunotherapy, great challenges still exist including severe toxic effects, high cost, drug resistance, and low response rates. Phototherapy is also a powerful treatment pattern, which has attracted tremendous interest with the advantages like noninvasive treatments and limited side effects and drug resistance . Photodynamic therapy (PDT) and photothermal therapy (PTT) are two main strategies applied for phototherapy of cancer. , PDT mainly utilizes reactive oxygen species (ROS) generated from photosensitizers for the destruction of cancer cells and the disruption of microvascular, which has already been sanctioned by the Food and Drug Administration of America (FDA). , ROS molecules ( e.g. , hydrogen peroxide, superoxide, singlet oxygen, and hydroxyl radical) usually have very short life spans and narrow radiuses .…”
Section: Introductionmentioning
confidence: 99%